- Rating
- 3
- Confidence
- 3
- Informativeness
- 3
- Presentation
- 3
- Soundness
- 2
Read review
Paper summary
-
Research problem and motivation. This work investigates de novo molecular glue design, a challenging problem in computational drug discovery that requires jointly generating a small molecule and determining the relative arrangement of two proteins to form a plausible ternary complex. Unlike conventional structure-based drug design, the protein–protein interface is unknown beforehand, making molecular generation and protein docking inherently interdependent.
-
Methodological innovation. The authors propose TriGlue, a biology-inspired generative framework that decomposes ternary complex generation into two stages. First, an SE(3)-equivariant interface estimation module predicts the potential protein–protein interface from unbound monomer structures. Then, an interface-conditioned ternary flow matching network jointly generates the molecular glue, predicts its atomic and bond attributes, and determines the target protein’s rigid-body transformation.
-
Experimental results. Experiments on TernaryDB demonstrate promising performance in molecular generation and ternary complex reconstruction. TriGlue achieves favorable molecular quality metrics compared with existing molecular generation baselines and improves protein docking performance over methods such as DeepTernary, EquiDock, and DiffDock-PP. The authors also demonstrate the benefits of explicit interface conditioning and few-shot adaptation across different molecular glue families.
Critical strengths
-
Molecular glue design is challenging because it requires identifying a suitable protein–protein interface while simultaneously designing a small molecule that facilitates ternary complex formation. By formulating this task as joint molecular generation and ternary complex reconstruction, the work addresses a meaningful gap in conventional structure-based drug design.
-
TriGlue combines SE(3)-equivariant interface estimation with interface-conditioned flow matching to jointly generate molecular glues and predict protein docking poses, with experiments demonstrating improvements over selected baselines.
Critical weaknesses
- The lack of comparisons with all-atom approaches for docking and ternary complex generation. TriGlue uses a residue-level interface representation to guide protein docking and molecular glue generation, but does not compare its interface estimation module with existing interface prediction methods such as CPORT, or its docking strategy with all-atom approaches such as HADDOCK and RosettaDock. Furthermore, comparisons with all-atom complex prediction models, such as AlphaFold 3 and Boltz-1, could help assess whether explicitly modeling atomic-level interactions improves ternary complex assembly and clarify the advantages of TriGlue's approach.
- Limited exploration of alternative interface hypotheses. TriGlue relies on a single predicted protein–protein interface to condition ternary complex generation, potentially limiting its ability to capture alternative binding modes. Generating and evaluating multiple plausible interface hypotheses could improve the diversity and success rate of ternary complex design, particularly when the interface is uncertain.
Questions for authors
- Could the authors explore generating multiple plausible protein–protein interface hypotheses rather than relying on a single predicted interface? This could allow TriGlue to capture alternative binding modes and improve ternary complex generation, particularly when the interface is uncertain.
- Regarding all-atom modeling: Could the authors compare TriGlue with at least one interface prediction and docking methods, such as CPORT, HADDOCK, and RosettaDock, as well as all-atom complex prediction models such as AlphaFold 3 and Boltz-1? Such comparisons could clarify the advantages of the residue-level interface representation and assess whether explicitly modeling atomic-level interactions improves ternary complex generation.
2 comments
With the discussion deadline approaching, we would like to kindly check whether our rebuttal and additional evaluations (including the all-atom dMaSIF interface comparison, AlphaFold3 complex benchmark, and multi-interface discussion) satisfactorily resolve the points in your review. Please let us know if any further feedback or clarification would be helpful. An overview of all current rebuttal updates is also available in our General Response at the top of the thread.
This year's ICLR process has been particularly challenging for reviewers and authors. We are truly grateful for your time, constructive feedback, and dedicated service to the community.
Response to Reviewer P5e4
We thank the reviewer for recognizing the value of our work and for suggesting these additional comparisons.
A: We added dMaSIF [1] with all-atom inputs and AlphaFold3 [2] as complementary benchmarks for interface estimation and ternary-complex prediction, respectively.
(1) Interface estimation. We compared TriGlue with dMaSIF using the same interface-evaluation metrics. As shown in the following Table, TriGlue achieves lower errors across all four metrics, supporting the effectiveness of its interface representation relative to these alternatives, including the baseline using all-atom inputs.
(2) All-atom structure prediction. We evaluated AlphaFold3 on the test set using both protein sequences and reference ligand SMILES, we measured ligand localization and geometric agreement with the reference. We observe that TriGlue yields lower ligand localization and geometric matching errors, with Hungarian-RMSD of 1.96 Å versus 6.18 Å for AlphaFold3. These comparisons complement the existing docking baselines and directly assess interface estimation and ligand placement within the assembled complex.
A: We thank the reviewer for this valuable suggestion. In future versions, we plan to sample multiple spatially distinct interface hypotheses, generate ternary complexes conditioned on each, and rank the candidates by interface compatibility and steric clashes. This would broaden exploration of alternative binding modes when the interface is uncertain.
The new comparisons with all-atom dMaSIF (Appendices H.2, H.5, and I.6) and AlphaFold3 (Appendix I.4) have been added in blue to the revised Appendix. We hope these additions address your points.
[1] Fast End-to-End Learning on Protein Surfaces. CVPR, 2021.
[2] Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature, 2024.